MQSA Small Entity Compliance Guide

The U.S. Food and Drug Administration (FDA) issued a Small Entity Compliance Guide (SECG) to assist small entities, including mammography facilities, in complying with the FDA’s March 2023 final rule amending regulations under the Mammography Quality Standards Act of 1992 (MQSA) and the Federal Food, Drug, and Cosmetic Act.

The amendments, which become effective September 10, 2024, will help modernize the regulations by incorporating current science and mammography best practices. Read the SECG